Vectors Research Management, LLC Eli Lilly & CO Transaction History

Vectors Research Management, LLC

$330 Million
Q3 2024

A detailed history of Vectors Research Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Vectors Research Management, LLC holds 4,324 shares of LLY stock, worth $3.51 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares

4,324

Previous 4,324 -0.0%

Holding current value

$3.51 Million

Previous $3.92 Million 1.99%

% of portfolio

1.16%

Previous 1.2%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $6,523 - $8,181	-9 Reduced 0.21%	4,324 $3.92 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $80.3 Million - $107 Million	-135,617 Reduced 96.9%	4,333 $3.37 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $71.2 Million - $83.9 Million	135,535 Added 3069.88%	139,950 $2.47 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $10,867 - $14,982	-25 Reduced 0.56%	4,415 $2.37 Million
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $9,119 - $12,193	-26 Reduced 0.58%	4,440 $2.08 Million
Q1 2023 May 04, 2023	SELL	$310.63 - $364.82 $62,126 - $72,964	-200 Reduced 4.29%	4,466 $1.53 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $8,094 - $10,045	36 Added 0.78%	4,666 $1.29 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $71,753 - $94,946	550 Added 13.48%	4,630 $782,000
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $14,622 - $16,913	100 Added 2.51%	4,080 $604,000
Q1 2019 Jul 15, 2019	BUY	$111.31 - $131.02 $443,013 - $521,459	3,980 New	3,980 $516,000
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $421,482 - $472,187	-3,980 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$85.86 - $107.31 $341,722 - $427,093	3,980 New	3,980 $342,000

Others Institutions Holding LLY

# of Institutions

4,073

Shares Held

737M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $771B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.

Account

Vectors Research Management, LLC Eli Lilly & CO Transaction History